In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
A consortium of 13 research institutions, including Cornell, received a $1.5 million grant from The Andrew W. Mellon Foundation to launch the Ivy+ Mellon Leadership Fellows program this fall.
Osei Boateng ’18, MHA ’20, founder of OKB Hope Foundation, a nonprofit dedicated to transforming health care delivery in Africa, is the latest guest on the Startup Cornell podcast.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
After service in the military, Chris Brunkhorst and Caleb Jones sought new outlets to channel their discipline and their commitment to helping others – and they both found it in neuroscience.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
A special type of cell, called an osteocyte, may hold the key to some of the mysteries of osteoporosis. A research group led by Karl Lewis, assistant professor of biomedical engineering, is studying osteocytes in unique new ways.
An analysis of beeswax in managed honeybee hives in New York finds a wide variety of pesticide, herbicide and fungicide residues, exposing current and future generations of bees to long-term toxicity.
In response to the COVID-19 pandemic, faculty in Cornell’s Public Health Program developed an innovative online training program to help boost skills in the public health workforce. A recent study recently reports that 94% of participants gained skills and knowledge they could apply directly to their work, and 86% developed a better understanding of public health.
